Status:

RECRUITING

Evaluation of Regenerative Potential in Horizontal Bone Loss Using VCMX Along With LASER Therapy

Lead Sponsor:

Postgraduate Institute of Dental Sciences Rohtak

Conditions:

Bone Loss, Alveolar

Eligibility:

All Genders

18-45 years

Phase:

NA

Brief Summary

Background- Periodontitis, an inflammatory disease of the periodontium, is one of the major causes of tooth mortality. Of all the bone destruction patterns that are present in periodontitis, horizonta...

Detailed Description

Periodontitis is a chronic inflammatory disease triggered by gram-negative anaerobic microbes and involves chronic inflammation that causes the destruction of the tooth-supporting apparatus and can le...

Eligibility Criteria

Inclusion

  • Periodontitis stage 2 and stage 3 patients will be enrolled according to criteria of 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions
  • Horizontal bone loss defects with depth ≥ 5 mm (initially analyzed by trans-gingival probing and intraoral periapical radiographs and will be confirmed further after flap elevation and CBCT)
  • PPD ≥ 5 mm
  • CAL ≥ 3 mm
  • Tooth mobility \< grade 1
  • Experimental teeth and adjacent teeth would be required to be vital and free of caries or dental restorations

Exclusion

  • Any systemic illness that could affect the periodontium or outcome of periodontal therapy
  • patients on medications such as corticosteroids or calcium channel blockers
  • long-term nonsteroidal anti-inflammatory drug therapy
  • pregnant or lactating women
  • current and past smoker
  • Periodontitis stage 4
  • teeth with one-wall defect, the presence of exostoses and ledges, grade II and grade III mobile teeth, defects extending to a root furcation area, unrestorable teeth, fractured/perforated roots, developing permanent teeth, endodontically treated teeth, and teeth with premature contact and dental prosthesis.

Key Trial Info

Start Date :

April 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2025

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06204588

Start Date

April 1 2024

End Date

March 1 2025

Last Update

May 17 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Post Graduate Institute of Dental Sciences

Rohtak, Haryana, India, 124001

Evaluation of Regenerative Potential in Horizontal Bone Loss Using VCMX Along With LASER Therapy | DecenTrialz